Dr. Anne De Groot to Speak at Immunotoxicity conference Jan 31 – Feb 1, 2013 in San Diego, CA

Dr. Anne De Groot Speaking at Immunotoxicity Conference San Diego, CA

Dr. Anne De Groot CEO/CSO EpiVax will present the keynote address at the Inaugural Immunogenicity and Immunotoxicity Conference (Jan 31 – Feb 1, 2013 in San Diego, CA)

Immune responses directed against protein therapeutics can directly impact drug safety and efficacy. The ability to predict and reduce immunogenicity of a potential protein therapeutic presents tremendous benefits at every stage of drug development. While many factors contribute to protein immunogenicity, T cell-dependent responses play a critical role. Modulation of T cell responses by blocking up-regulatory receptors, or concomitant treatment with cytotoxic drugs has also been attempted with varying degrees of success. Tregitopes have now been demonstrated to reduce immune response to antigens in an antigen-specific manner.

The ability to analyze, predict, and modify the immunogenicity of a protein expands the available strategies for mitigating therapeutic protein immunogenicity, enables quality by design for drugs in development and improvement of licensed biologics to create biobetters.

The Inaugural Immunogenicity and Immunotoxicity conference will bring together a mix of academic and industry experts from leading affiliations (such as MedImmune, Roche, Ambryx, Aegis Therapeutics, Antitope, Epiontis, Amgen, EpiVax, Ablynx, Eleven Biotherapeutics, Bayer HealthCare and more) to cover many current and relevant aspects of Immunogenicity and Immunotoxicity.

This conference is also part of the 2nd Novel Cancer Therapeutic Summit, which consists of this track and three other tracks:
1) 5th Immunotherapeutics and Immunomonitoring
2) 11th Cytokines and Inflammation
3) 2nd Allergy & Respiratory Drug Discovery

For more information, please visit www.gtcbio.com

Contact Details

Company Name: GTC
Issued By: Scott Mccue
Phone: 6262566405
Address: 635 W. Foothill Blvd. Monrovia, CA 91016
City: Monrovia
State: CA
Zip: 91016
Country: United States
Website: Visit the website

Keywords : Anne De Groot, Immunotoxicity, Immunogenicity, Immunomodulation, Deimmunization, Biologics, Nonclinical, Safety, Evaluation, Human, Medicines, Translational Immunotoxicology,

by Scott Mccue (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.